Quest Diagnostics Market Cap 2010-2023 | DGX

Quest Diagnostics market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Quest Diagnostics market cap as of April 18, 2024 is $13.98B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $13.983B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $15.884B 9.61
DaVita (DVA) United States $11.060B 15.05
Chemed (CHE) United States $9.031B 28.42
Encompass Health (EHC) United States $7.873B 21.60
Elanco Animal Health (ELAN) United States $6.690B 15.25
Option Care Health (OPCH) United States $5.371B 21.02
RadNet (RDNT) United States $3.260B 95.22
Amedisys (AMED) United States $2.966B 21.16
LifeStance Health (LFST) United States $2.174B 0.00
Astrana Health (ASTH) United States $2.056B 25.94
Addus HomeCare (ADUS) United States $1.577B 24.17
U.S Physical Therapy (USPH) United States $1.469B 38.08
Pennant (PNTG) United States $0.604B 34.90
Aveanna Healthcare Holdings (AVAH) United States $0.416B 0.00
Atai Life Sciences (ATAI) Germany $0.317B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00